Nan Fung Group Holdings
Nan Fung Group Holdings reported 25 stocks worth $131M in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are MPLT (26.5%), LBRX (15.6%) and EVMN (14.6%). Compared with Q1 2026, the fund opened new positions in ASND and CHYM, trimmed OCS and BOLT and sold out of ASND.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  MPLT Maplight Therapeutics Inc | $34.8M | 26.5% | 971K | No change | 3 of 8 | |
| 2 |  LBRX LB Pharmaceuticals Inc | $20.5M | 15.6% | 631K | No change | 4 of 8 | |
| 3 |  EVMN Evommune Inc | $19.2M | 14.6% | 1.4M | No change | 3 of 8 | |
| 4 | CYBIN INC | $6.5M | 5.0% | 987K | +527K (+115%) | 3 of 8 | |
| 5 |  INCY Incyte Corp | $6.1M | 4.6% | 54K | No change | 8 of 8 | |
| 6 |  RYTM Rhythm Pharmaceuticals Inc | $5.5M | 4.2% | 49K | No change | 8 of 8 | |
| 7 |  ONC Beone Medicines Ltd | $4.5M | 3.4% | 16K | No change | 8 of 8 | |
| 8 |  OCS Oculis Holding AG | $4.2M | 3.2% | 301K | −50K (−14%) | 8 of 8 | |
| 9 |  ASND Ascendis Pharma A/s | $3.6M | 2.8% | 14K | New position | 1 of 8 | |
| 10 |  RVMD Revolution Medicines Inc | $3.6M | 2.7% | 19K | No change | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
ASND Ascendis Pharma A/s | $3.1M | 14K |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 13, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Nan Fung Group Holdings 13F FAQ
What does Nan Fung Group Holdings own?
Nan Fung Group Holdings reported 25 stocks worth $131M in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are MPLT (26.5%), LBRX (15.6%) and EVMN (14.6%). The table above lists every position in the filing (the top 10 without an account).
What did Nan Fung Group Holdings buy and sell in Q2 2026?
Compared with Q1 2026: 2 new positions, 1 added to, 2 trimmed and 1 sold out. New positions include ASND and CHYM. It sold all of ASND.
When will Nan Fung Group Holdings file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Nan Fung Group Holdings's portfolio worth?
The Q2 2026 filing reports $131M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.